Not six months later, in December of that year, Blooms team had proof that GLP-1 had passed the first big test
Common pathological processes in Alzheimer disease and type 2 diabetes: a review
Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, et al
There may be benefits
By keeping an eye on important metrics like weight, hunger levels, blood sugar, and side effects, healthcare providers can fine-tune treatments and tackle challenges like plateaus
* Correspondence: Xinshu Li, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers